Management of psoriasis and its comorbidities in primary care

British Journal of Nursing

Volumn 20, Issue 18, 2011, Pages 1186-1192

  Aldeen, Taha ^a   Basra, Mohammad ^b  

^a BASILDON HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Primary care; Psoriasis; Psoriasis comorbidities

Indexed keywords

EID: 80054866576     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2011.20.18.1186     Document Type: Article

References (32)

1. Akbari A, Mayhew A, Al-Alawi MA et al (2008) Interventions to improve outpatient referrals from primary care to secondary care. Cochrane Database Syst Rev. Oct. 8;(4): CD005471.
2. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I (2009) Epidemiology and co-morbidity of psoriasis in children. Br J Dermatol 162(3): 633-6
3. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M (2010) Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol 90(2): 147-51
4. Benton EC, Kerr OA, Fisher A, Fraser SJ, McCormack SK, Tidman MJ (2008) The changing face of dermatological practice: 25 years' experience. Br J Dermatol 159(2): 413-8 (Pubitemid 352009876)
5. Brauchli YB, Jick SS, Miret M, Meier CR (2009) Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 160(5): 1048-56
6. Brauchli YB, Jick SS, Miret M, Meier CR (2009) Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 129(11): 2604-12
7. British Association of Dermatologists and Primary Care Dermatology Society (2010) Recommendations for the initial management of psoriasis. http://tinyurl.com/5ukmu6m (accessed 27 September 2011)
8. Burden AD, Hilton Boon M, Leman J, Wilson H, Richmond R, Ormerod AD; Guideline Development Group (2010) Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance. BMJ 341: c5623
9. Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34(3): J314-21
10. de Berker D (2009) Management of psoriatic nail disease. Semin Cutan Med Surg 28(1): 39-43
11. Eedy DJ, Griffiths CE, Chalmers RJ et al (2009) Care of patients with psoriasis: an audit of U.K. services in secondary care. Br J Dermatol 160(3): 557-64
12. Eghlileb AM, Davies EE, Finlay AY (2007) Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 156(6): 1245-50 (Pubitemid 47029819)
13. Feldman SR, Evans C, Russell MW (2005) Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a northeastern US managed care plan. J Dermatolog Treat 16(1): 37-42 (Pubitemid 40283323)
14. Fowler JF, Duh MS, Rovba L et al. (2008) The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol 59(5): 772-80
15. Garg A, Gladman D (2010) Recognizing psoriatic arthritis in the dermatology clinic. J Am Acad Dermatol 63(5): 733-48
16. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141(12): 1537-41 (Pubitemid 41815843)
17. Gillard SE, Finlay AY (2005) Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in the primary care. Int J Clin Pract 59(11): 1260-7 (Pubitemid 43904493)
18. Griffiths CEM, Taylor H, Collins SI et al. (2006) The impact of psoriasis guidelines on appropriateness of referral from primary to secondary care: a randomized controlled trial. Br J Dermatol 155(2): 393-400 (Pubitemid 44050575)
19. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370(9583): 263-71 (Pubitemid 47069537)
20. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M (2007) Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 57(6): 963-71 (Pubitemid 350087343)
21. Magin P, Adams J, Heading G, Pond D, Smith W (2009) The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med 14(2): 150-61
22. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31(8): 1000-6
23. Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374(9690): 609-19
24. Nast A, Spuls PH, Ormerod AD et al (2009) A critical appraisal of evidencebased guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol 23(7): 782-7
25. Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE (2004) Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 151(6): 1227-33 (Pubitemid 40030171)
26. Salisbury C, Noble A, Horrocks S et al (2005) Evaluation of a general practitioner with special interest service for dermatology: randomised controlled trial. BMJ 331(7530): 1441-6
27. Schmitt J, Ford DE (2010) Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 24(8): 885-92
28. Smith N, Weymann A, Tausk FA, Gelfand JM (2009) Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. J Am Acad Dermatol 61(5): 841-56
29. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9(2): 136-9 (Pubitemid 38457271)
30. Uhlenhake EE, Kurkowski D, Feldman SR (2009) Conversations on psoriasis - what patients want and what physicians can provide: A qualitative look at patient and physician expectations. J Dermatolog Treat 21(1): 6-12
31. Warren RB, Kleyn CE and Gulliver WP (2011) Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course. BJD 164(Suppl 1): 1-14
32. Zaghloul SS, Goodfield MJ (2004) Objective assessment of compliance with psoriasis treatment. Arch Dermatol 140(4): 408-14 (Pubitemid 38469243)